National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 7/16/2021 release of VAERS data:

Found 1,445 cases where Vaccine is HPV2 and Serious

Table

   
AgeCountPercent
< 3 Years40.28%
6-9 Years10.07%
9-12 Years805.54%
12-17 Years71749.62%
17-44 Years24316.82%
44-65 Years80.55%
Unknown39227.13%
TOTAL1,445100%



Case Details

This is page 1 out of 145

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 391384 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Ohio  
Vaccinated:2010-03-25
Onset:2010-05-01
   Days after vaccination:37
Submitted: 2010-06-24
   Days after onset:54
Entered: 2010-06-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS A4PVA085BC / 2 LA / UN

Administered by: Private       Purchased by: Private
Symptoms: Electromyogram abnormal, Grip strength decreased, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: no
Preexisting Conditions: no
Allergies:
Diagnostic Lab Data: EMG positive, spinal tap positive, other causes ruled out during hospitalization
CDC Split Type:

Write-up: Hand numbness then loss of grip strength then progressed to leg weakness gradual onset. EMG positive for Guillain Barre Syndrome and Hospitalized for IVIG on 06/16/2010. Resolution of symptoms at office visit on 06/23/2010.


VAERS ID: 435174 (history)  
Form: Version 1.0  
Age: 25.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2011-08-01
Onset:0000-00-00
Submitted: 2011-09-22
Entered: 2011-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA113AA / 1 RA / IJ

Administered by: Private       Purchased by: Private
Symptoms: Intra-uterine death, Maternal exposure during pregnancy, Uterine dilation and curettage
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: no
Preexisting Conditions: no
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient was 2-3 weeks pregnant at time of vaccination. Possible birth defect caused fetal demise at 6 weeks 6 days of gestation. DNC was required.


VAERS ID: 451701 (history)  
Form: Version 1.0  
Age: 30.0  
Sex: Female  
Location: Maryland  
Vaccinated:2011-03-25
Onset:2011-06-05
   Days after vaccination:72
Submitted: 2012-03-12
   Days after onset:281
Entered: 2012-03-14
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA102AB / 2 LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Exploratory operation, Hepatic mass, Hepatic neoplasm malignant non-resectable, Jaundice, Laboratory test, Laparotomy, Nausea, Palliative care, Pruritus generalised, Terminal state, Ultrasound abdomen abnormal, Vomiting
SMQs:, Liver related investigations, signs and symptoms (narrow), Cholestasis and jaundice of hepatic origin (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Liver malignant tumours (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2011-12-24
   Days after onset: 202
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 19 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: On 8/30/2011 subject reported by phone that she had started on 6/5/2011 with diffuse abdominal pain of moderate-to-severe intensity, nausea, vomits, generalized pruritus, and jaundice. Abdominal sonogram on 7/22/2011 showed a mass in the liver. Local hospital admission (7/23/2011) and testing led to referral to national hospital and exploratory laparotomy (8/8/2011), and discovery of liver tumor (5 cm diameter) in the portal vein bifurcation with infiltration of the extrahepatic bile duct. Tumor was unremovable. She was discharged 8/11/2011 with treatment against pruritus and referral to Oncology (appt 9/7/2011). On 12/22/2011 subject was in terminal phase, receiving palliative care at home; diagnosis was liver cancer.


VAERS ID: 451703 (history)  
Form: Version 1.0  
Age: 28.0  
Sex: Female  
Location: Maryland  
Vaccinated:2005-02-16
Onset:2010-06-03
   Days after vaccination:1933
Submitted: 2012-03-12
   Days after onset:648
Entered: 2012-03-14
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS VX10787 / 3 LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Chemotherapy, Colitis, Hysterectomy, Mass excision, Metastasis, Ovarian cancer stage III, Ovarian disorder, Pelvic discomfort, Pelvic pain, Stomach mass, Ultrasound ovary abnormal
SMQs:, Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal nonspecific inflammation (narrow), Ischaemic colitis (broad), Ovarian malignant tumours (narrow), Uterine and fallopian tube tumours of unspecified malignancy (broad), Noninfectious diarrhoea (broad), Non-haematological malignant tumours (narrow), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2011-10-23
   Days after onset: 507
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Between June-August 2010, subject started with pain/discomfort in pelvic region. She consulted her local primary care center and was diagnosed and treated for colitis. After symptomology progressively worsened she was given a sonogram (8/25/2010) that showed "shadows on ovaries". Following readmission (8/30/2010), surgeons on 9/1/2010 removed a mass apparently started in the stomach; they told subject''s sister it was invasive cancer. Hospital admission and multiple chemotherapy courses took place in 9/2010 and 10/2010, then total hysterectomy (1/28/2011) and more chemo (5/2011). On 6/22/2011 she was admitted with diagnosis of ovarian cancer stage III C. Was taking Hyoscine, methadone, and bisacodyl as necessary.


VAERS ID: 453908 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Male  
Location: Washington  
Vaccinated:2011-08-30
Onset:2012-04-12
   Days after vaccination:226
Submitted: 2012-04-16
   Days after onset:4
Entered: 2012-04-17
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA113AA / 1 RA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U3846AA / 1 LA / IM

Administered by: Private       Purchased by: Unknown
Symptoms: Asthma, Blood glucose increased, Cachexia, Condition aggravated, Cough, Dehydration, Diarrhoea, Glucose urine present, Polydipsia, Polyuria, Type 1 diabetes mellitus, Urine ketone body present, Weight decreased, Wrong drug administered
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (narrow), Hyperglycaemia/new onset diabetes mellitus (narrow), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Noninfectious diarrhoea (narrow), Tubulointerstitial diseases (broad), Medication errors (narrow), Dehydration (narrow), Hypokalaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Mild asthma
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Per mother since vaccination, pt started to lose weight & was diagnosed with Type I DM 4/12/12, concerned because pt was given CERVARIX in error.


VAERS ID: 463963 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2012-05-14
Onset:2012-05-14
   Days after vaccination:0
Submitted: 2012-09-04
   Days after onset:113
Entered: 2012-09-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA113BB / 1 UN / UN
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1295AA / UNK UN / UN

Administered by: Private       Purchased by: Private
Symptoms: Fatigue, Influenza like illness, Nausea, Oedema peripheral, Pain
SMQs:, Cardiac failure (broad), Acute pancreatitis (broad), Angioedema (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: The subject had no concomitant medications and no known allergies.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0991830A

Write-up: This case was reported by a physician, via a sales representative, and described the occurrence of body pain in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline), VARIVAX (non-gsk). On 14 May 2012 at 16:30 the subject received 1st dose of CERVARIX (.5 ml, unknown route) and on 14 May 2012 the subject received 2nd dose of VARIVAX (Non-GSK) (details unknown). On 14 May 2012, 1 hour after vaccination with CERVARIX and VARIVAX (Non-GSK), the subject experienced "overall" body pain, swelling arm, flu like symptoms, fatigue and nausea. The physician considered the events were disabling. The events lasted for 3 days. On 17 May 2012, the events were resolved. The subject consulted her healthcare provider. The vaccination course with CERVARIX was discontinued.


VAERS ID: 472685 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Georgia  
Vaccinated:2010-09-02
Onset:2012-09-22
   Days after vaccination:751
Submitted: 2012-10-27
   Days after onset:35
Entered: 2012-11-02
   Days after submission:6
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS 0216V / 1 LA / IM

Administered by: Private       Purchased by: Other
Symptoms: Abasia, Abdominal pain upper, Crying, Haematemesis, Headache, Loss of consciousness, Muscle spasms, Panic attack, Pelvic pain, Urticaria
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dystonia (broad), Gastrointestinal haemorrhage (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations: Adverse event.~HPV (no brand name)~1~13.00~Patient
Other Medications: None
Current Illness: No
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Dr. gave 1st HPV 9-2-10. Within a few days, pt. passed out, in 2 weeks passed out again. Spit up blood, bad headaches, stomach ache, hives. Dr. gave her HPV shot; recommended booster in 1 month. She passed out a week later, had panic attack, bad headaches, stomach and pelvic pain, legs cramping up at night. Waking crying, couldn''t walk at first.


VAERS ID: 491885 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: Indiana  
Vaccinated:2013-05-10
Onset:2013-05-10
   Days after vaccination:0
Submitted: 2013-05-17
   Days after onset:7
Entered: 2013-05-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA174BJ / 2 LA / IM

Administered by: Private       Purchased by: Public
Symptoms: Blood gases, Blood glucose, Cardiac monitoring, Computerised tomogram head, Dizziness, Drug screen, Electrocardiogram, Full blood count, Grip strength decreased, Headache, Incoherent, Metabolic function test, Somnolence
SMQs:, Anticholinergic syndrome (broad), Dementia (broad), Drug abuse and dependence (broad), Psychosis and psychotic disorders (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Vestibular disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Metformin 1 tablet qd
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CBC; CMV; CT scan head; Hospital stay x24h
CDC Split Type:

Write-up: About 5:30 pm patient c/o headache. C/O mom found patient in tub asleep about 6 pm. Patient got out of tub was in moms room bent over to pick up cup. Patient could not grab a hold of cup. C/O dizziness, talking to mom incoherently. Took to ER local. Patient was real drowsy want to sleep. ER did - EKG, blood test, B/S, Blood gases CT scan drug testing U/A. ER couldn''t find out the problem. Transfer by helicopter to hospital. Heart monitored overnight. Patient was fine the next morning.


VAERS ID: 495540 (history)  
Form: Version 1.0  
Age: 31.0  
Sex: Female  
Location: Maryland  
Vaccinated:2006-05-02
Onset:2012-09-25
   Days after vaccination:2338
Submitted: 2013-06-28
   Days after onset:276
Entered: 2013-06-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS VX17027 / 1 LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2012-09-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Subject was enrolled in Vaccine Trial and received 3 doses of CERVARIX. Following closeout from CVT in 12/17/2010, patient continued in Extended Follow-up Study (since 8/1/2011). At study visit on 6/21/2013, parents-in-law of patient reported she passed away at home on 9/25/2012. Patient has hx of severe dilated cardiomyopathy starting in 2008, and suffered severe respiratory illnesses and a stroke in 2010 and 2011, respectively. Cause of death was believed to be related to her underlying heart condition and not related to vaccination.


VAERS ID: 534568 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2014-03-20
Onset:2014-04-28
   Days after vaccination:39
Submitted: 2014-06-21
   Days after onset:54
Entered: 2014-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS PH43F / 3 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Blindness unilateral, Eye pain, Headache, Lumbar puncture, Nuclear magnetic resonance imaging, Optic neuritis
SMQs:, Glaucoma (broad), Optic nerve disorders (narrow), Demyelination (narrow), Retinal disorders (broad), Ocular infections (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: MRI, Lumbar Puncture
CDC Split Type:

Write-up: Patient began severe headache with rght eye pain which lasted for three weeks and was misdiagnosed as a sinus infection and migraine. Patient lost complete vision in right eye and was diagnosed with optic neuritis on 5/21/2014 and hospitalized.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&VAX=HPV2&SERIOUS=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166